Ajou University Industry-Academic Cooperation Foundation
发明人:
申请号:
EP06799011.9
公开号:
EP1951268B1
申请日:
2006.09.29
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
Mesenchymal stem cells expressing a suicide gene show excellent and highly selective anticancer effects against cancer tissues through the selective conversion of a prodrug of an anticancer agent to the anticancer agent at around the cancer. Also disclosed herein are a pharmaceutical composition for treating a cancer comprising the mesenchymal stem cell; a kit for treating a cancer comprising an expression vector comprising the suicide gene, the mesenchymal stem cell and the prodrug; and a method for treating a cancer patient, which comprises successively administering the mesenchymal stem cell and the prodrug to the patient.